US Patent Issued to CuraSen Therapeutics on Sept. 1 for "Alpha 1A -adrenergic receptor agonists and methods of use" (California Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,038, issued on Sept. 1, was assigned to CuraSen Therapeutics Inc. (San Carlos, Calif.).

"Alpha 1A -adrenergic receptor agonists and methods of use" was invented by David Scott Carter (San Carlos, Calif.) and Anthony P. Ford (San Carlos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to chemical compounds and, in some embodiments, to Alpha1A-adrenergic receptor agonists and uses of such agonists in the treatment of diseases associated with an adrenergic receptor. Disclosed herein is a compound according to Formula (I) or an optically pure stereoisomer, pharmaceutically acceptable salt, solvate, or prodr...